Vaccine Reactions

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-08-08
Clinical Trial Update: Effect of High-Dose Quadrivalent Influenza Vaccine (Efluelda®) Versus Standard-Dose (QIV-SD), in Subjects 65 Years of Age and Older on Innate Immunity, Including Gene Expression [Phase 4]
A Phase 4 trial comparing high-dose quadrivalent influenza vaccine Efluelda with standard-dose QIV-SD in adults 65+ assessing innate immunit…